{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,22]],"date-time":"2026-04-22T01:56:06Z","timestamp":1776822966953,"version":"3.51.2"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2002,3,1]],"date-time":"2002-03-01T00:00:00Z","timestamp":1014940800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Best Practice &amp; Research Clinical Haematology"],"published-print":{"date-parts":[[2002,3]]},"DOI":"10.1053\/beha.2002.0184","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:24:48Z","timestamp":1027682688000},"page":"37-57","source":"Crossref","is-referenced-by-count":58,"title":["Molecular monitoring of residual disease using antigen receptor genes in childhood acute lymphoblastic leukaemia"],"prefix":"10.1053","volume":"15","author":[{"given":"Tomasz","family":"Szczepa\u0144ski","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Flohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincent H.J.","family":"van der Velden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claus R.","family":"Bartram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques J.M.","family":"van Dongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1053\/beha.2002.0184_RF1","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1038\/sj.leu.2401977","article-title":"Long-term results of large prospective trials in childhood acute lymphoblastic leukemia","volume":"14","author":"Schrappe","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF2","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1038\/302575a0","article-title":"Somatic generation of antibody diversity","volume":"302","author":"Tonegawa","year":"1983","journal-title":"Nature"},{"key":"10.1053\/beha.2002.0184_RF3","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1038\/334395a0","article-title":"T-cell antigen receptor genes and T-cell recognition","volume":"334","author":"Davis","year":"1988","journal-title":"Nature"},{"key":"10.1053\/beha.2002.0184_RF4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0009-8981(91)90246-9","article-title":"Analysis of immunoglobulin and T cell receptor genes. Part I: Basic and technical aspects","volume":"198","author":"van Dongen","year":"1991","journal-title":"Clinica Chimica Acta"},{"key":"10.1053\/beha.2002.0184_RF5","series-title":"Leukemia","first-page":"83","article-title":"Immunobiology of leukemia","author":"van Dongen","year":"1996"},{"key":"10.1053\/beha.2002.0184_RF6","first-page":"155","article-title":"In vitro amplification of T cell gamma gene rearrangements: a new tool for the assessment of minimal residual disease in acute lymphoblastic leukemias","volume":"3","author":"d'Auriol","year":"1989","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF7","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1182\/blood.V74.5.1762.1762","article-title":"Detection of minimal residual disease in acute lymphoblastic leukemia by in vitro amplification of rearranged T-cell receptor delta chain sequences","volume":"74","author":"Hansen-Hagge","year":"1989","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF8","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1056\/NEJM199008163230705","article-title":"Minimal residual disease in childhood B-lineage lymphoblastic leukemia. Persistence of leukemic cells during the first 18 months of treatment","volume":"323","author":"Yamada","year":"1990","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0184_RF9","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1182\/blood.V82.10.3063.3063","article-title":"Southern blot patterns, frequencies and junctional diversity of T-cell receptor \u03b4 gene rearrangements in acute lymphoblastic leukemia","volume":"82","author":"Breit","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF10","doi-asserted-by":"crossref","first-page":"2151","DOI":"10.1084\/jem.188.11.2151","article-title":"The complete nucleotide sequence of the human immunoglobulin heavy chain variable region locus","volume":"188","author":"Matsuda","year":"1998","journal-title":"Journal of Experimental Medicine"},{"key":"10.1053\/beha.2002.0184_RF11","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/sj.leu.2402206","article-title":"Precursor-B-ALL with D H -J H gene rearrangements have an immature immunogenotype with a high frequency of oligoclonality and hyperdiploidy of chromosome 14","volume":"15","author":"Szczepa\u0144ski","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF12","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.leu.2401245","article-title":"Primers and protocols for standardized MRD detection in ALL using immunoglobulin and T cell receptor gene rearrangements and TAL1 deletions as PCR targets. Report of the BIOMED-1 Concerted Action: Investigation of minimal residual disease in acute leukemia","volume":"13","author":"Pongers-Willemse","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF13","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1182\/blood.V84.2.574.574","article-title":"Characterization of clone-specific rearranged T-cell receptor gamma-chain genes in lymphomas and leukemias by the polymerase chain reaction and DNA sequencing","volume":"84","author":"Kneba","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF14","first-page":"1841","article-title":"Detection of clonal immunoglobulin gene rearrangements by polymerase chain reaction amplification and single-strand conformational polymorphism analysis","volume":"142","author":"Davis","year":"1993","journal-title":"American Journal of Pathology"},{"key":"10.1053\/beha.2002.0184_RF15","doi-asserted-by":"crossref","first-page":"8536","DOI":"10.1073\/pnas.87.21.8536","article-title":"Rapid, nonradioactive detection of clonal T-cell receptor gene rearrangements in lymphoid neoplasms","volume":"87","author":"Bourguin","year":"1990","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2002.0184_RF16","doi-asserted-by":"crossref","first-page":"3271","DOI":"10.1182\/blood.V83.11.3271.3271","article-title":"Heteroduplex analysis of T-cell receptor gamma gene rearrangements for diagnosis and monitoring of cutaneous T-cell lymphomas","volume":"83","author":"Bottaro","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF17","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1038\/sj.leu.2400887","article-title":"Heteroduplex PCR analysis of rearranged T cell receptor genes for clonality assessment in suspect T cell proliferations","volume":"11","author":"Langerak","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF18","first-page":"840","article-title":"Identification and structural analysis of rearranged immunoglobulin heavy chain genes in lymphomas and leukemias","volume":"9","author":"Linke","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF19","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2141.1991.tb08570.x","article-title":"Immunoglobulin gene \u2018fingerprinting\u2019: an approach to analysis of B lymphoid clonality in lymphoproliferative disorders","volume":"77","author":"Deane","year":"1991","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF20","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1182\/blood.V86.10.3930.bloodjournal86103930","article-title":"Analysis of rearranged T-cell receptor beta-chain genes by polymerase chain reaction (PCR) DNA sequencing and automated high resolution PCR fragment analysis","volume":"86","author":"Kneba","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF21","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0009-8981(91)90247-A","article-title":"Analysis of immunoglobulin and T cell receptor genes. Part II: Possibilities and limitations in the diagnosis and management of lymphoproliferative diseases and related disorders","volume":"198","author":"van Dongen","year":"1991","journal-title":"Clinica Chimica Acta"},{"key":"10.1053\/beha.2002.0184_RF22","first-page":"2228","article-title":"Detection of immunoglobulin kappa light-chain gene rearrangement patterns by Southern blot analysis","volume":"8","author":"Beishuizen","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF23","first-page":"657","article-title":"Multiple rearranged immunoglobulin genes in childhood acute lymphoblastic leukemia of precursor B-cell origin","volume":"5","author":"Beishuizen","year":"1991","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF24","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/sj.leu.2401985","article-title":"Immunoglobulin lambda isotype gene rearrangements in B-cell malignancies","volume":"15","author":"T\u00fcmkaya","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF25","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/316260a0","article-title":"A uniform deleting element mediates the loss of kappa genes in human B cells","volume":"316","author":"Siminovitch","year":"1985","journal-title":"Nature"},{"key":"10.1053\/beha.2002.0184_RF26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/sj.leu.2401745","article-title":"Immunoglobulin kappa gene rearrangements between the kappa deleting element and Jkappa recombination signal sequences in acute lymphoblastic leukemia and normal hematopoiesis","volume":"14","author":"Seriu","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF27","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI113103","article-title":"T cell receptor alpha-, beta-, and gamma-genes in T cell and pre-B cell acute lymphoblastic leukemia","volume":"80","author":"Felix","year":"1987","journal-title":"Journal of Clinical Investigation"},{"key":"10.1053\/beha.2002.0184_RF28","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/sj.leu.2401277","article-title":"Cross-lineage T-cell receptor gene rearrangements occur in more than ninety percent of childhood precursor-B-acute lymphoblastic leukemias: alternative PCR targets for detection of minimal residual disease","volume":"13","author":"Szczepa\u0144ski","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF29","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/sj.leu.2401276","article-title":"Immunophenotypic and immunogenotypic characteristics of TCR\u03b3\u03b4+ T cell acute lymphoblastic leukemia","volume":"13","author":"Langerak","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF30","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1046\/j.1365-2141.2001.02772.x","article-title":"Two consecutive immunophenotypic switches in a child with immunogenotypically stable acute leukaemia","volume":"113","author":"Bierings","year":"2001","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF31","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1182\/blood.V77.1.141.141","article-title":"T-cell receptor delta gene recombination in common acute lymphoblastic leukemia: preferential usage of V delta 2 and frequent involvement of the J alpha cluster","volume":"77","author":"Yokota","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF32","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1182\/blood.V86.2.692.bloodjournal862692","article-title":"Frequent ongoing T-cell receptor rearrangements in childhood B-precursor acute lymphoblastic leukemia: implications for monitoring minimal residual disease","volume":"86","author":"Steenbergen","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF33","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1038\/sj.leu.2401071","article-title":"Immunoglobulin and T cell receptor gene rearrangement patterns in acute lymphoblastic leukemia are less mature in adults than in children: implications for selection of PCR targets for detection of minimal residual disease","volume":"12","author":"Szczepa\u0144ski","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF34","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1182\/blood.V96.6.2254","article-title":"The incidence of clonal T-cell receptor rearrangements in B-cell precursor acute lymphoblastic leukemia varies with age and genotype","volume":"96","author":"Brumpt","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF35","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1038\/sj.leu.2400904","article-title":"Heterogeneity in junctional regions of immunoglobulin kappa deleting element rearrangements in B cell leukemias: a new molecular target for detection of minimal residual disease","volume":"11","author":"Beishuizen","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF36","first-page":"207","article-title":"Development of human T lymphocytes and their thymus-dependency","volume":"16","author":"van Dongen","year":"1990","journal-title":"Thymus"},{"key":"10.1053\/beha.2002.0184_RF37","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1038\/sj.leu.2401765","article-title":"T cell receptor gamma (TCRG) gene rearrangements in T cell acute lymphoblastic leukemia reflect \u2018end-stage\u2019 recombinations: implications for minimal residual disease monitoring","volume":"14","author":"Szczepa\u0144ski","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF38","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1182\/blood.V93.12.4079","article-title":"Ig heavy chain gene rearrangements in T-cell acute lymphoblastic leukemia exhibit predominant D H 6\u201319 and D H 7\u201327 gene usage, can result in complete V-D-J rearrangements, and are rare in T-cell receptor \u03b1\u03b2 lineage","volume":"93","author":"Szczepa\u0144ski","year":"1999","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF39","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/0009-8981(93)90239-Z","article-title":"Detection of minimal residual leukemia by the polymerase chain reaction: potential implications for therapy","volume":"217","author":"Bartram","year":"1993","journal-title":"Clinica Chimica Acta"},{"key":"10.1053\/beha.2002.0184_RF40","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/S1470-2045(00)00418-6","article-title":"Minimal residual disease in leukaemia patients","volume":"2","author":"Szczepa\u0144ski","year":"2001","journal-title":"Lancet Oncology"},{"key":"10.1053\/beha.2002.0184_RF41","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1038\/sj.leu.2402184","article-title":"T lymphocytes in bone marrow samples of children with acute lymphoblastic leukemia during and after chemotherapy might hamper PCR-based minimal residual disease studies","volume":"15","author":"van Wering","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF42","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1046\/j.1365-2141.2000.02143.x","article-title":"Regenerating normal B-cell precursors during and after treatment of acute lymphoblastic leukaemia: implications for monitoring of minimal residual disease","volume":"110","author":"van Wering","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF43","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/sj.leu.2401749","article-title":"Regeneration pattern of precursor-B-cells in bone marrow of acute lymphoblastic leukemia patients depends on the type of preceding chemotherapy","volume":"14","author":"van Lochem","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF44","first-page":"444","article-title":"Quantitation of targets for PCR by use of limiting dilution","volume":"13","author":"Sykes","year":"1992","journal-title":"Biotechniques"},{"key":"10.1053\/beha.2002.0184_RF45","first-page":"321","article-title":"Accurate quantitation of residual B-precursor acute lymphoblastic leukemia by limiting dilution and a PCR-based detection system: a description of the method and the principles involved","volume":"9","author":"Ouspenskaia","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF46","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1182\/blood.V83.7.1892.1892","article-title":"Prospective monitoring and quantitation of residual blasts in childhood acute lymphoblastic leukemia by polymerase chain reaction study of delta and gamma T-cell receptor genes","volume":"83","author":"Cave","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF47","series-title":"Encyclopedia of Genetics","article-title":"Polymerase chain reaction, real-time quantitative","author":"van der Velden","year":"2001"},{"key":"10.1053\/beha.2002.0184_RF48","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1101\/gr.6.10.986","article-title":"Real time quantitative PCR","volume":"6","author":"Heid","year":"1996","journal-title":"Genome Research"},{"key":"10.1053\/beha.2002.0184_RF49","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.1073\/pnas.88.16.7276","article-title":"Detection of specific polymerase chain reaction product by utilizing the 5\u2032\u20133\u2032 exonuclease activity ofThermus aquaticus DNA polymerase","volume":"88","author":"Holland","year":"1991","journal-title":"Proceedings of the National Academy of Sciences of the USA"},{"key":"10.1053\/beha.2002.0184_RF50","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1038\/sj.leu.2401246","article-title":"Real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia using junctional regions specific TaqMan probes","volume":"12","author":"Pongers-Willemse","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF51","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/sj.leu.2401801","article-title":"Application of germline IGH probes in real-time quantitative PCR for the detection of minimal residual disease in acute lymphoblastic leukemia","volume":"14","author":"Verhagen","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF52","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1038\/sj.leu.2401831","article-title":"Improved assessment of minimal residual disease in B cell malignancies using fluorogenic consensus probes for real-time quantitative PCR","volume":"14","author":"Br\u00fcggemann","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF53","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1038\/sj.leu.2401655","article-title":"Potential of LightCycler technology for quantification of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"14","author":"Eckert","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF54","first-page":"3281","article-title":"Rapid and reliable quantification of minimal residual disease in acute lymphoblastic leukemia using rearranged immunoglobulin and T-cell receptor loci by LightCycler technology","volume":"60","author":"Nakao","year":"2000","journal-title":"Cancer Research"},{"key":"10.1053\/beha.2002.0184_RF55","first-page":"205","article-title":"Unusual immunoglobulin and T-cell receptor gene rearrangement patterns in acute lymphoblastic leukemias","volume":"246","author":"Szczepa\u0144ski","year":"1999","journal-title":"Current Topics in Microbiology and Immunology"},{"key":"10.1053\/beha.2002.0184_RF56","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1084\/jem.168.1.229","article-title":"Continuing rearrangement but absence of somatic hypermutation in immunoglobulin genes of human B cell precursor leukemia","volume":"168","author":"Bird","year":"1988","journal-title":"Journal of Experimental Medicine"},{"key":"10.1053\/beha.2002.0184_RF57","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1182\/blood.V81.3.775.775","article-title":"Immunoglobulin heavy chain gene V H -D junctional diversity at diagnosis in patients with acute lymphoblastic leukemia","volume":"81","author":"Kitchingman","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF58","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1182\/blood.V83.5.1355.1355","article-title":"A polymerase chain reaction study of the stability of Ig heavy-chain and T-cell receptor delta gene rearrangements between presentation and relapse of childhood B-lineage acute lymphoblastic leukemia","volume":"83","author":"Steward","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF59","first-page":"60","article-title":"Differences in immunoglobulin heavy chain gene rearrangement patterns between bone marrow and blood samples in childhood precursor B-acute lymphoblastic leukemia at diagnosis","volume":"7","author":"Beishuizen","year":"1993","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF60","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1182\/blood.V83.8.2238.2238","article-title":"Analysis of Ig and T-cell receptor genes in 40 childhood acute lymphoblastic leukemias at diagnosis and subsequent relapse: implications for the detection of minimal residual disease by polymerase chain reaction analysis","volume":"83","author":"Beishuizen","year":"1994","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF61","doi-asserted-by":"crossref","first-page":"2795","DOI":"10.1182\/blood.V85.10.2795.bloodjournal85102795","article-title":"Heterogeneity of the T-cell receptor delta gene indicating subclone formation in acute precursor B-cell leukemias","volume":"85","author":"Ghali","year":"1995","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF62","first-page":"60","article-title":"Characterisation of non-concordance in the T-cell receptor gamma chain genes at presentation and clinical relapse in acute lymphoblastic leukemia","volume":"8","author":"Taylor","year":"1994","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF63","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1038\/sj.leu.2401970","article-title":"Quantification of minimal residual disease in children with oligoclonal B-precursor acute lymphoblastic leukemia indicates that the clones that grow out during relapse already have the slowest rate of reduction during induction therapy","volume":"15","author":"De Haas","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF64","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/sj.leu.2401269","article-title":"Clonal stability in children with acute lymphoblastic leukemia (ALL) who relapsed five or more years after diagnosis","volume":"13","author":"LoNigro","year":"1999","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF65","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1016\/S0140-6736(98)04058-6","article-title":"Prognostic value of minimal residual disease in acute lymphoblastic leukaemia in childhood","volume":"352","author":"van Dongen","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0184_RF66","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1182\/blood.V77.2.331.331","article-title":"Use of polymerase chain reactions to monitor minimal residual disease in acute lymphoblastic leukemia patients","volume":"77","author":"Yokota","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF67","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1182\/blood.V78.3.739.739","article-title":"Detection of minimal residual disease in T-cell acute lymphoblastic leukemia using polymerase chain reaction predicts impending relapse","volume":"78","author":"Neale","year":"1991","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF68","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1200\/JCO.1992.10.12.1879","article-title":"Residual disease at the end of induction therapy as a predictor of relapse during therapy in childhood B-lineage acute lymphoblastic leukemia","volume":"10","author":"Wasserman","year":"1992","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0184_RF69","first-page":"282","article-title":"Minimal residual disease in childhood acute lymphoblastic leukemia: analysis of patients in continuous complete remission or with consecutive relapse","volume":"6","author":"Biondi","year":"1992","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF70","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1200\/JCO.1993.11.3.546","article-title":"Molecular residual disease status at the end of chemotherapy fails to predict subsequent relapse in children with B-lineage acute lymphoblastic leukemia","volume":"11","author":"Ito","year":"1993","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0184_RF71","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1182\/blood.V82.5.1618.1618","article-title":"Long-term follow-up of residual disease in acute lymphoblastic leukemia patients in complete remission using clonogeneic IgH probes and the polymerase chain reaction","volume":"82","author":"Nizet","year":"1993","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF72","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0140-6736(94)90988-1","article-title":"Outcome prediction in childhood acute lymphoblastic leukaemia by molecular quantification of residual disease at the end of induction","volume":"343","author":"Brisco","year":"1994","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0184_RF73","first-page":"1726","article-title":"Prolonged persistence of PCR-detectable minimal residual disease after diagnosis or first relapse predicts poor outcome in childhood B-precursor acute lymphoblastic leukemia","volume":"9","author":"Steenbergen","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF74","first-page":"615","article-title":"Prospective monitoring of minimal residual disease during the course of chemotherapy in patients with acute lymphoblastic leukemia, and detection of contaminating tumor cells in peripheral blood stem cells for autotransplantation","volume":"9","author":"Seriu","year":"1995","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF75","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1056\/NEJM199701303360501","article-title":"Measurement of residual leukemia during remission in childhood acute lymphoblastic leukemia","volume":"336","author":"Roberts","year":"1997","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0184_RF76","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1182\/blood.V90.3.1226","article-title":"Detectable molecular residual disease at the beginning of maintenance therapy indicates poor outcome in children with T-cell acute lymphoblastic leukemia","volume":"90","author":"Dibenedetto","year":"1997","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF77","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1038\/sj.leu.2400985","article-title":"Minimal residual disease after intensive induction therapy in childhood acute lymphoblastic leukemia predicts outcome","volume":"12","author":"Gruhn","year":"1998","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF78","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1046\/j.1365-2141.1998.00574.x","article-title":"Minimal residual disease analysis for the prediction of relapse in children with standard-risk acute lymphoblastic leukaemia","volume":"100","author":"Goulden","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF79","doi-asserted-by":"crossref","first-page":"3616","DOI":"10.1200\/JCO.1998.16.11.3616","article-title":"Residual disease detection using fluorescent polymerase chain reaction at 20 weeks of therapy predicts clinical outcome in childhood acute lymphoblastic leukemia","volume":"16","author":"Evans","year":"1998","journal-title":"Journal of Clinical Oncology"},{"key":"10.1053\/beha.2002.0184_RF80","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1056\/NEJM199808273390904","article-title":"Clinical significance of minimal residual disease in childhood acute lymphoblastic leukemia","volume":"339","author":"Cave","year":"1998","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0184_RF81","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/S0140-6736(97)10295-1","article-title":"Immunological detection of minimal residual disease in children with acute lymphoblastic leukaemia","volume":"351","author":"Coustan-Smith","year":"1998","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0184_RF82","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1365-2141.1997.1792996.x","article-title":"A prospective study of minimal residual disease in childhood B-lineage acute lymphoblastic leukaemia: MRD level at the end of induction is a strong predictive factor of relapse","volume":"98","author":"Jacquy","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF83","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1182\/blood.V95.3.790.003k48_790_794","article-title":"Rapid molecular response during early induction chemotherapy predicts a good outcome in childhood acute lymphoblastic leukemia","volume":"95","author":"Panzer-Grumayer","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF84","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1038\/sj.leu.2401922","article-title":"Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features","volume":"14","author":"Biondi","year":"2000","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF85","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1055\/s-2008-1026781","article-title":"Corticosteroid-dependent reduction of leukocyte count in blood as a prognostic factor in acute lymphoblastic leukemia in childhood (therapy study ALL-BFM 83)","volume":"199","author":"Riehm","year":"1987","journal-title":"Klinische Padiatrie"},{"key":"10.1053\/beha.2002.0184_RF86","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/j.1365-2141.1999.01365.x","article-title":"Investigation of minimal residual disease in childhood and adult acute lymphoblastic leukaemia by molecular analysis","volume":"105","author":"Foroni","year":"1999","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF87","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200004063421402","article-title":"Outcome of treatment in children with Philadelphia chromosome-positive acute lymphoblastic leukemia","volume":"342","author":"Arico","year":"2000","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0184_RF88","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1038\/sj.leu.2400759","article-title":"Effect of the Philadelphia chromosome on minimal residual disease in acute lymphoblastic leukemia","volume":"11","author":"Brisco","year":"1997","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF89","first-page":"96","article-title":"A prospective study of residual-disease monitoring of the ALL1\/AF4 transcript in patients with t(4;11) acute lymphoblastic leukemia","volume":"95","author":"Cimino","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF90","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1002\/(SICI)1097-0142(19980901)83:5<1055::AID-CNCR44>3.0.CO;2-3","article-title":"Intensified therapy for infants with acute lymphoblastic leukemia: results from the Dana-Farber Cancer Institute Consortium","volume":"83","author":"Szczepa\u0144ski","year":"1998","journal-title":"Cancer"},{"key":"10.1053\/beha.2002.0184_RF91","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1046\/j.1365-2141.2000.02434.x","article-title":"Minimal residual disease studies are beneficial in the follow-up of TEL\/AML1 patients with B-precursor acute lymphoblastic leukaemia","volume":"111","author":"De Haas","year":"2000","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF92","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1056\/NEJM199310283291801","article-title":"Treatment of acute lymphoblastic leukemia. 30 years' experience at St Jude Children's Research Hospital","volume":"329","author":"Rivera","year":"1993","journal-title":"New England Journal of Medicine"},{"key":"10.1053\/beha.2002.0184_RF93","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/sj.leu.2402019","article-title":"MRD at the end of induction therapy in childhood acute lymphoblastic leukemia: outcome prediction strongly depends on the therapeutic regimen","volume":"15","author":"Zur Stadt","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF94","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/S0140-6736(01)06355-3","article-title":"Prognostic value of minimal residual disease in relapsed childhood acute lymphoblastic leukaemia","volume":"358","author":"Eckert","year":"2001","journal-title":"Lancet"},{"key":"10.1053\/beha.2002.0184_RF95","doi-asserted-by":"crossref","first-page":"4072","DOI":"10.1182\/blood.V92.11.4072","article-title":"Minimal residual disease status before allogeneic bone marrow transplantation is an important determinant of successful outcome for children and adolescents with acute lymphoblastic leukemia","volume":"92","author":"Knechtli","year":"1998","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF96","first-page":"414a","article-title":"Impact of minimal residual disease prior to allogeneic stem cell transplantation in children with ALL","volume":"96","author":"Bader","year":"2000","journal-title":"Blood"},{"key":"10.1053\/beha.2002.0184_RF97","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1038\/sj.leu.2402198","article-title":"Real-time quantitative PCR for detection of minimal residual disease before allogeneic stem cell transplantation predicts outcome in children with acute lymphoblastic leukemia","volume":"15","author":"van der Velden","year":"2001","journal-title":"Leukemia"},{"key":"10.1053\/beha.2002.0184_RF98","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1046\/j.1365-2141.1998.00873.x","article-title":"Minimal residual disease status as a predictor of relapse after allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia","volume":"102","author":"Knechtli","year":"1998","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF99","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1046\/j.1365-2141.1997.3723186.x","article-title":"Monitoring minimal residual disease in peripheral blood in B-lineage acute lymphoblastic leukaemia","volume":"99","author":"Brisco","year":"1997","journal-title":"British Journal of Haematology"},{"key":"10.1053\/beha.2002.0184_RF100","first-page":"60","article-title":"Minimal residual disease in childhood acute lymphoblastic leukaemia quantified by aspirate and trephine: is the disease multifocal?","volume":"103","author":"Sykes","year":"1998","journal-title":"British Journal of Haematology"}],"container-title":["Best Practice &amp; Research Clinical Haematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602901842?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521692602901842?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T22:20:43Z","timestamp":1704320443000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521692602901842"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2002,3]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2002,3]]}},"alternative-id":["S1521692602901842"],"URL":"https:\/\/doi.org\/10.1053\/beha.2002.0184","relation":{},"ISSN":["1521-6926"],"issn-type":[{"value":"1521-6926","type":"print"}],"subject":[],"published":{"date-parts":[[2002,3]]}}}